Working with TipRanks
Follow Us
Stocks
ETFs
Options
Commodities
Crypto
Currency
Research Tools
Calendars
Economic Indicators
Calculators
Education
About Us
Working with TipRanks
Follow Us
Celldex Therapeutics Inc (GB:0HUU)
LSE:0HUU
Celldex (0HUU) Share Price & Analysis
0 Followers
0HUU Stock Chart & Stats
Day’s Range$0 - $0
52-Week Range$0.44 - $0.44
Previous Close$0.44
Volume0.00
Average Volume (3M)N/A
Market Cap
$2.81B
Enterprise Value$2.57B
Total Cash (Recent Filing)$235.35M
Total Debt (Recent Filing)$2.85M
Price to Earnings (P/E)-0.2
BetaN/A
Next Earnings
Aug 07, 2024EPS EstimateN/A
Next Dividend Ex-DateN/A
Dividend YieldN/A
Share Statistics
EPS (TTM)-2.91
Shares Outstanding55,900,679
10 Day Avg. Volume0
30 Day Avg. VolumeN/A
Standard Deviation0.34
R-Squared0.00510
Alpha-0.08
Financial Highlights & Ratios
Price to Book (P/B)5.68
Price to Sales (P/S)9.54
Price to Cash Flow (P/CF)-17.60
P/FCF Ratio0.00
Enterprise Value/Market CapN/A
Enterprise Value/Revenue589.38
Enterprise Value/Gross Profit1.09K
Enterprise Value/Ebitda-29.06
Forecast
1Y Price Target
$69.67Price Target Upside15734.09% Upside
Rating ConsensusStrong Buy
Number of Analyst Covering7
Celldex News
Options Prices
Currently, No data available
---
Ownership Overview
18.40% Insiders
29.63% Mutual Funds
14.35% Other Institutional Investors
37.62% Public Companies and
Individual Investors
0HUU FAQ
What was Celldex Therapeutics Inc’s price range in the past 12 months?
Celldex Therapeutics Inc lowest share price was $0.44 and its highest was $0.44 in the past 12 months.
What is Celldex Therapeutics Inc’s market cap?
Currently, no data Available
When is Celldex Therapeutics Inc’s upcoming earnings report date?
Celldex Therapeutics Inc’s upcoming earnings report date is Aug 07, 2024 which is in 94 days.
How were Celldex Therapeutics Inc’s earnings last quarter?
Celldex Therapeutics Inc released its earnings results on May 02, 2024. The company reported -$0.69 earnings per share for the quarter, beating the consensus estimate of -$0.693 by $0.003.
Is Celldex Therapeutics Inc overvalued?
According to Wall Street analysts Celldex Therapeutics Inc’s price is currently Undervalued.
Does Celldex Therapeutics Inc pay dividends?
Celldex Therapeutics Inc does not currently pay dividends.
What is Celldex Therapeutics Inc’s EPS estimate?
Celldex Therapeutics Inc’s EPS estimate for its next earnings report is not yet available.
How many shares outstanding does Celldex Therapeutics Inc have?
Celldex Therapeutics Inc has 65,910,545 shares outstanding.
What happened to Celldex Therapeutics Inc’s price movement after its last earnings report?
Celldex Therapeutics Inc reported an EPS of -$0.69 in its last earnings report, beating expectations of -$0.693. Following the earnings report the stock price went same 0%.
Which hedge fund is a major shareholder of Celldex Therapeutics Inc?
Among the largest hedge funds holding Celldex Therapeutics Inc’s share is Woodline Partners LP. It holds Celldex Therapeutics Inc’s shares valued at 15M.
---
Celldex Stock Smart Score
Outperform
1
2
3
4
5
6
7
8
9
10
Analyst Consensus
Strong Buy
Average Price Target:
$69.67 (15734.09% Upside)
$69.67 (15734.09% Upside)
Blogger Sentiment
Bullish
GB:0HUU Sentiment 100%
Sector Average 70%
Sector Average 70%
Insider Transactions
Bought Shares
Worth $93.1K over
the Last 3 Months
the Last 3 Months
Technicals
SMA
Positive
20 days / 200 days
Momentum
35.28%
12-Months-Change
Fundamentals
Return on Equity
-37.45%
Trailing 12-Months
Asset Growth
32.00%
Trailing 12-Months
Company Description
Celldex Therapeutics Inc
Celldex Therapeutics, Inc. engages in the research, development, and commercialization of immunotherapies and other targeted biologics. Its drug candidates have the ability to engage the human immune system and directly inhibit tumors to treat specific types of cancer and other diseases. Its pipeline includes Varlilumab, CDX-1140, and CDX-301, and CDX-3379. The company was founded by Anthony S. Marucci and Tibor Keler in 1983 and is headquartered in Hampton, NJ.
---
0HUU Stock 12 Months Forecast
Average Price Target
$69.67
▲(15734.09% Upside)
Technical Analysis
Best Analysts Covering 0HUU
1 Year
1 Year Success Rate
10/11 ratings generated profit
1 Year Average Return
+22.77%
reiterated a buy rating 19 days ago
Copying Joseph Pantginis's trades and holding each position for 1 Year would result in 90.91% of your transactions generating a profit, with an average return of +22.77% per trade.
---